Bcl∷ChemInfo - Qualitative analysis of machine learning models for activation of HSD involved in Alzheimer's Disease

Author(s):  
Mariusz Butkiewicz ◽  
Edward W. Lowe ◽  
Jens Meiler
2021 ◽  
Vol 2021 ◽  
pp. 1-12
Author(s):  
Morshedul Bari Antor ◽  
A. H. M. Shafayet Jamil ◽  
Maliha Mamtaz ◽  
Mohammad Monirujjaman Khan ◽  
Sultan Aljahdali ◽  
...  

Alzheimer’s disease has been one of the major concerns recently. Around 45 million people are suffering from this disease. Alzheimer’s is a degenerative brain disease with an unspecified cause and pathogenesis which primarily affects older people. The main cause of Alzheimer’s disease is Dementia, which progressively damages the brain cells. People lost their thinking ability, reading ability, and many more from this disease. A machine learning system can reduce this problem by predicting the disease. The main aim is to recognize Dementia among various patients. This paper represents the result and analysis regarding detecting Dementia from various machine learning models. The Open Access Series of Imaging Studies (OASIS) dataset has been used for the development of the system. The dataset is small, but it has some significant values. The dataset has been analyzed and applied in several machine learning models. Support vector machine, logistic regression, decision tree, and random forest have been used for prediction. First, the system has been run without fine-tuning and then with fine-tuning. Comparing the results, it is found that the support vector machine provides the best results among the models. It has the best accuracy in detecting Dementia among numerous patients. The system is simple and can easily help people by detecting Dementia among them.


2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Javier De Velasco Oriol ◽  
Edgar E. Vallejo ◽  
Karol Estrada ◽  
José Gerardo Taméz Peña ◽  
The Alzheimer’s Disease Neuroimaging Initiative

Abstract Background Late-Onset Alzheimer’s Disease (LOAD) is a leading form of dementia. There is no effective cure for LOAD, leaving the treatment efforts to depend on preventive cognitive therapies, which stand to benefit from the timely estimation of the risk of developing the disease. Fortunately, a growing number of Machine Learning methods that are well positioned to address this challenge are becoming available. Results We conducted systematic comparisons of representative Machine Learning models for predicting LOAD from genetic variation data provided by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort. Our experimental results demonstrate that the classification performance of the best models tested yielded ∼72% of area under the ROC curve. Conclusions Machine learning models are promising alternatives for estimating the genetic risk of LOAD. Systematic machine learning model selection also provides the opportunity to identify new genetic markers potentially associated with the disease.


2019 ◽  
Author(s):  
Nicole Ludwig ◽  
Tobias Fehlmann ◽  
Manfred Gogol ◽  
Walter Maetzler ◽  
Stephanie Deutscher ◽  
...  

AbstractBackgroundTo develop therapeutics for Alzheimer’s disease, early detection of patients awakes new hope. Circulating small non-coding RNAs are among the prominent candidates for a blood-based diagnosis, requiring however growing cohort sizes.MethodsWe determined abundance levels of 21 known circulating microRNAs in 465 individuals encompassing Alzheimer’s patients and controls recruited in US and Germany. We computed models to assess the relation between microRNA-expression and phenotypes, gender, age and disease severity (Mini-Mental State Examination MMSE).Results20 of 21 miRNAs were consistently dys-regulated in the US and Germany. 18 were significantly correlated to neurodegeneration (adjusted p<0.05) with highest significance for miR-532-5p (adjusted p=4.8×10−30). Ten miRNAs were significantly correlated with MMSE, in particular miR-26a/26b-5p (adjusted p=0.0002). Machine learning models reached an AUC value of 87.6% in differentiating AD patients from controls.ConclusionsOur data provide strong evidence for the relevance of circulating non-coding RNAs to detect Alzheimer’s from a blood sample.


Author(s):  
Zhiwei Zeng ◽  
Zhiqi Shen ◽  
Benny Toh Hsiang Tan ◽  
Jing Jih Chin ◽  
Cyril Leung ◽  
...  

Argumentation has gained traction as a formalism to make more transparent decisions and provide formal explanations recently. In this paper, we present an argumentation-based approach to decision making that can support modelling and automated reasoning about complex qualitative preferences and offer dialogical explanations for the decisions made. We first propose Qualitative Preference Decision Frameworks (QPDFs). In a QPDF, we use contextual priority to represent the relative importance of combinations of goals in different contexts and define associated strategies for deriving decision preferences based on prioritized goal combinations. To automate the decision computation, we map QPDFs to Assumption-based Argumentation (ABA) frameworks so that we can utilize existing ABA argumentative engines for our implementation. We implemented our approach for two tasks, diagnostics and prognostics of Alzheimer's Disease (AD), and evaluated it with real-world datasets. For each task, one of our models achieves the highest accuracy and good precision and recall for all classes compared to common machine learning models. Moreover, we study how to formalize argumentation dialogues that give contrastive, focused and selected explanations for the most preferred decisions selected in given contexts.


2020 ◽  
Vol 2 (1) ◽  
pp. 3-6
Author(s):  
Eric Holloway

Imagination Sampling is the usage of a person as an oracle for generating or improving machine learning models. Previous work demonstrated a general system for using Imagination Sampling for obtaining multibox models. Here, the possibility of importing such models as the starting point for further automatic enhancement is explored.


Sign in / Sign up

Export Citation Format

Share Document